Pancreatitis Trial, Recruiting NCT05878236 Sponsor: Ohio State University Condition: Pancreatitis
Back to Pancreatitis

Pancreatitis Trial, Recruiting

NCT05878236
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 75 years old at the time of joining the study
  • People who have been diagnosed with acute pancreatitis (a sudden inflammation of the pancreas) based on specific medical criteria — this means having at least two of the following: upper abdominal pain, blood enzyme levels (amylase or lipase) at least three times higher than normal, or medical imaging showing signs of acute pancreatitis
  • People who are contacted by the research team within 36 hours of arriving at the hospital
  • People who fully understand the study and agree to take part, including signing a consent form, completing interviews and forms, and providing biological samples (such as blood)

Who may not be able to join:

  • People who have already been diagnosed with definite chronic pancreatitis (long-term, ongoing pancreas inflammation), confirmed by CT scan, MRI, or a related imaging test showing calcium deposits or certain blockages in the pancreas
  • People whose acute pancreatitis was caused by a medical procedure called ERCP and who are expected to stay in hospital for less than 48 hours
  • People who have a pancreatic tumour, including certain types of cancer or tumours that have spread to the pancreas
  • People who have a certain type of cyst on the pancreas that is believed to be causing their pancreatitis or is linked to a widened pancreatic duct (confirm with trial site)
  • People who have previously had surgery on the pancreas, such as removal of part or all of the pancreas or related procedures
  • People with serious ongoing health conditions that the research team believes could affect the study results or put the person at greater risk — this includes a history of organ transplant, AIDS, active cancer treatment within the past 12 months (except certain minor skin cancers), severe kidney disease or dialysis, liver cirrhosis, or any condition the site doctor believes means a life expectancy of less than 12 months
  • People who are known to be pregnant at the time of joining the study
  • People who are currently incarcerated
  • People with any other condition or circumstance that the research team believes could affect their safety or the reliability of the study results

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 614-685-3619

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ohio State University
Registry
ClinicalTrials.gov
Start date
6 March 2023
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Multi-Cytokine Panel Validation; Cytokine Signature Correlation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov